Mahic Milada, Che Xiaoyu, Susser Ezra, Levin Bruce, Reichborn-Kjennerud Ted, Magnus Per, Stoltenberg Camilla, Chauhan Lokendrasingh, Briese Thomas, Bresnahan Michaeline, Surén Pål, Hornig Mady, Mjaaland Siri, Lipkin W Ian
Center for Infection and Immunity, Mailman School of Public Health, Columbia University, New York, New York, USA.
Norwegian Institute of Public Health, Oslo, Norway.
mSphere. 2017 Jun 21;2(3). doi: 10.1128/mSphere.00159-17. eCollection 2017 May-Jun.
The literature concerning gestational maternal influenza virus infection and risk of autism spectrum disorders (ASD) is inconclusive. To address this uncertainty, we obtained information from questionnaires and samples from the Autism Birth Cohort, a prospective birth cohort comprising mothers, fathers, and offspring recruited in Norway in 1999 to 2008. Through questionnaires, referrals, and linkages to the Norwegian National Patient Registry, we identified 338 mothers of children with ASD and 348 frequency-matched controls for whom plasma samples that had been collected midpregnancy and after delivery were available for influenza virus serology via luciferase immunoprecipitation and hemagglutinin inhibition assays for influenza virus strains circulating during the study period. Assay data were combined to define serological status and integrated with self-reports of influenza-like illness to estimate ASD risk. Neither influenza A nor influenza B virus infection was associated with increased ASD risk. Integration of reports of symptoms of influenza-like illness with serology revealed an increase in risk for seropositive women with symptoms, but this increase did not achieve statistical significance (a level of < 0.05) in the comparison with seronegative women without symptoms (adjusted odds ratio, 1.93; 95% confidence interval, 0.95 to 3.89; = 0.068). Although chance may explain our findings, the magnitude of the potential association may be of biological importance, and dismissing our findings could result in failure to detect a bona fide association (type II error). If the association is true, we posit that the risk is due to activation of the maternal immune system following infection rather than direct fetal infection. Data on levels of cytokines or other mediators of inflammation would allow us to test the validity of this hypothesis. The causes of most cases of autism spectrum disorders (ASD) are unknown. Some epidemiological studies suggest that maternal gestational influenza virus infection may increase the risk of ASD in offspring. Here, we describe an analysis of a large birth cohort with results based on questionnaires that prospectively addressed subjective reports of influenza-like illness and serological assays for objective determination of influenza virus infection. Although serologic evidence of gestational influenza virus infection alone was not associated with risk, positive serology and symptoms of influenza-like illness cannot yet be definitely ruled out as a risk factor.
关于孕期母亲感染流感病毒与自闭症谱系障碍(ASD)风险之间关系的文献尚无定论。为了解决这一不确定性问题,我们从自闭症出生队列研究中获取了问卷信息和样本。该队列研究是一项前瞻性出生队列研究,于1999年至2008年在挪威招募了母亲、父亲及其子女。通过问卷、转诊以及与挪威国家患者登记处的关联,我们确定了338名自闭症患儿的母亲以及348名频率匹配的对照者,他们在孕期中期和分娩后采集的血浆样本可用于通过荧光素酶免疫沉淀法和血凝抑制试验检测研究期间流行的流感病毒株的流感病毒血清学。将检测数据综合起来以确定血清学状态,并与流感样疾病的自我报告相结合,以估计患自闭症谱系障碍的风险。甲型流感病毒感染和乙型流感病毒感染均与自闭症谱系障碍风险增加无关。将流感样疾病症状报告与血清学相结合发现,有症状的血清阳性女性的风险有所增加,但与无症状的血清阴性女性相比,这种增加未达到统计学显著性水平(<0.05)(调整后的比值比为1.93;95%置信区间为0.95至3.89;P = 0.068)。尽管偶然性可能解释我们的研究结果,但潜在关联的程度可能具有生物学重要性,忽视我们的研究结果可能导致无法检测到真正的关联(II类错误)。如果这种关联是真实的,我们推测风险是由于感染后母亲免疫系统的激活,而非直接的胎儿感染。细胞因子或其他炎症介质水平的数据将使我们能够检验这一假设的有效性。大多数自闭症谱系障碍(ASD)病例的病因尚不清楚。一些流行病学研究表明,孕期母亲感染流感病毒可能会增加后代患自闭症谱系障碍的风险。在此,我们描述了对一个大型出生队列的分析,其结果基于前瞻性处理流感样疾病主观报告的问卷以及用于客观确定流感病毒感染的血清学检测。尽管仅孕期流感病毒感染的血清学证据与风险无关,但血清学阳性和流感样疾病症状作为风险因素仍不能被明确排除。